Renaissance Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-10,496
| Closed | -$288K | – | 285 |
|
|
2019
Q3 | $288K | Buy |
10,496
+380
| +4% | +$10.4K | 0.01% | 236 |
|
|
2019
Q2 | $335K | Buy |
10,116
+202
| +2% | +$6.69K | 0.01% | 239 |
|
|
2019
Q1 | $347K | Sell |
9,914
-731
| -7% | -$25.6K | 0.01% | 236 |
|
|
2018
Q4 | $354K | Buy |
10,645
+437
| +4% | +$14.5K | 0.02% | 229 |
|
|
2018
Q3 | $514K | Buy |
10,208
+303
| +3% | +$15.3K | 0.02% | 222 |
|
|
2018
Q2 | $593K | Sell |
9,905
-771
| -7% | -$46.2K | 0.02% | 185 |
|
|
2018
Q1 | $489K | Buy |
10,676
+285
| +3% | +$13.1K | 0.02% | 191 |
|
|
2017
Q4 | $414K | Buy |
10,391
+96
| +0.9% | +$3.83K | 0.01% | 217 |
|
|
2017
Q3 | $412K | Sell |
10,295
-2,936
| -22% | -$117K | 0.01% | 207 |
|
|
2017
Q2 | $570K | Buy |
13,231
+308
| +2% | +$13.3K | 0.02% | 141 |
|
|
2017
Q1 | $404K | Sell |
12,923
-2,317
| -15% | -$72.4K | 0.02% | 165 |
|
|
2016
Q4 | $385K | Sell |
15,240
-36
| -0.2% | -$909 | 0.02% | 175 |
|
|
2016
Q3 | $378K | Sell |
15,276
-1,921
| -11% | -$47.5K | 0.02% | 164 |
|
|
2016
Q2 | $350K | Sell |
17,197
-3,829
| -18% | -$77.9K | 0.01% | 173 |
|
|
2016
Q1 | $321K | Buy |
+21,026
| New | +$321K | 0.01% | 173 |
|
|
2015
Q4 | – | Sell |
-19,873
| Closed | -$279K | – | 297 |
|
|
2015
Q3 | $279K | Buy |
+19,873
| New | +$279K | 0.01% | 218 |
|